Effects of Modafinil on Dopamine and Dopamine Transporters in the Male Human Brain: Clinical Implications

Modafinil is a wake-promoting drug widely used for narcolepsy and increasingly as an off-label cognitive enhancer. While it was initially marketed as having a distinct mechanism of action from traditional stimulants, recent preclinical evidence suggested it might interact with the dopamine system. This study aimed to determine if modafinil, at therapeutic doses (200 mg and 400 mg), increases extracellular dopamine and occupies dopamine transporters in the human brain.

Researchers conducted a positron emission tomography (PET) study on 10 healthy male participants. They used two specific radiotracers: [11C]raclopride, which is sensitive to changes in endogenous dopamine levels, and [11C]cocaine, which binds to dopamine transporters. By comparing PET scans taken after a placebo with those taken after oral modafinil administration, the team measured changes in binding potential to assess dopamine transporter occupancy and extracellular dopamine concentrations in the striatum and nucleus accumbens.

The study found that modafinil significantly reduced the binding potential of both radiotracers in the caudate, putamen, and nucleus accumbens. The reduction in [11C]cocaine binding indicates that modafinil occupies dopamine transporters, while the reduction in [11C]raclopride binding reflects a subsequent increase in extracellular dopamine. These effects were observed at both 200 mg and 400 mg doses, with the magnitude of dopamine transporter blockade comparable to that seen with therapeutic doses of methylphenidate.

These results challenge the long-standing assumption that modafinil operates through a non-dopaminergic mechanism. Because the drug increases dopamine in the nucleus accumbens—a brain region central to the reward and reinforcement pathways—the findings suggest that modafinil may carry a potential for abuse and dependence, particularly in vulnerable populations. This necessitates a more cautious approach to its increasing use as a cognitive enhancer.